IL-6 and IL-8 levels after cardiopulmonary bypass are not affected by surface coating
- PMID: 10585054
- DOI: 10.1016/s0003-4975(99)01066-8
IL-6 and IL-8 levels after cardiopulmonary bypass are not affected by surface coating
Abstract
BACKGROUND.:Contact of blood with the surfaces of the cardiopulmonary bypass (CPB) circuit has been implicated as a cause of the inflammatory response. We undertook a prospective randomized trial of 200 pediatric patients, all with a calculated total bypass flow of less than 2.3 L/min (< 0.96 L/m2/min).
Methods: Patients were randomly assigned to 1 of 4 CPB groups: (1) Nonheparin-bonded circuit with no albumin preprime; (2) Nonheparin-bonded circuit with albumin preprime; (3) Heparin-bonded circuit with no albumin preprime; (4) Heparin-bonded circuit with albumin preprime. Measurements of cytokines, (interleukin [IL]-6, IL-8) and blood cell counts were made prebypass and 6 and 24 hours after institution of cardiopulmonary bypass.
Results: Analysis of variance showed no significant difference in any of the clinical or biochemical characteristics of the 4 groups. The interaction between heparin-bonded oxygenators and albumin preprime was not significant. No important differences in IL-6 or IL-8 concentrations were noted after CPB using either heparin or nonheparin-bonded oxygenators with albumin or albumin free preprime using two-way analysis of variance.
Conclusions: Albumin preprime and heparin-bonding do not attenuate the inflammatory response component attributable to the concentration of these markers.
Comment in
-
Heparin coating of bypass systems.Ann Thorac Surg. 2000 Jul;70(1):335. doi: 10.1016/s0003-4975(00)01521-6. Ann Thorac Surg. 2000. PMID: 10921746 No abstract available.
Similar articles
-
Superior biocompatibility of heparin-bonded circuits in pediatric cardiopulmonary bypass.Jpn J Thorac Cardiovasc Surg. 1999 Dec;47(12):592-9. doi: 10.1007/BF03218070. Jpn J Thorac Cardiovasc Surg. 1999. PMID: 10658376 Clinical Trial.
-
Release of proinflammatory cytokines during pediatric cardiopulmonary bypass: heparin-bonded versus nonbonded oxygenators.Ann Thorac Surg. 1997 Dec;64(6):1790-4. doi: 10.1016/s0003-4975(97)00846-1. Ann Thorac Surg. 1997. PMID: 9436574 Clinical Trial.
-
Influence of two different perfusion systems on inflammatory response in pediatric heart surgery.Ann Thorac Surg. 2003 Mar;75(3):919-25. doi: 10.1016/s0003-4975(02)04501-0. Ann Thorac Surg. 2003. PMID: 12645717 Clinical Trial.
-
Heparin bonding of bypass circuits reduces cytokine release during cardiopulmonary bypass.Ann Thorac Surg. 1995 Sep;60(3):525-9. doi: 10.1016/0003-4975(95)00482-z. Ann Thorac Surg. 1995. PMID: 7677475
-
Cytokine responses to cardiopulmonary bypass: lessons learned from cardiac transplantation.Ann Thorac Surg. 1997 Jan;63(1):269-76. doi: 10.1016/s0003-4975(96)00931-9. Ann Thorac Surg. 1997. PMID: 8993291 Review.
Cited by
-
Identification of Inflammatory Gene in the Congenital Heart Surgery Patients following Cardiopulmonary Bypass via the Way of WGCNA and Machine Learning Algorithms.Dis Markers. 2023 Apr 12;2023:5493415. doi: 10.1155/2023/5493415. eCollection 2023. Dis Markers. 2023. PMID: 39281206 Free PMC article.
-
Monocyte adhesion to and transmigration through endothelium following cardiopulmonary bypass shearing is mediated by IL-8 signaling.Front Cardiovasc Med. 2024 Dec 11;11:1454302. doi: 10.3389/fcvm.2024.1454302. eCollection 2024. Front Cardiovasc Med. 2024. PMID: 39723411 Free PMC article.
-
Shear stress associated with cardiopulmonary bypass induces expression of inflammatory cytokines and necroptosis in monocytes.JCI Insight. 2021 Jan 11;6(1):e141341. doi: 10.1172/jci.insight.141341. JCI Insight. 2021. PMID: 33232305 Free PMC article.
-
A comparison of three dose timings of methylprednisolone in infant cardiopulmonary bypass.Springerplus. 2014 Aug 29;3:484. doi: 10.1186/2193-1801-3-484. eCollection 2014. Springerplus. 2014. PMID: 25221738 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical